This is usually an indication that you have a methylation defect and need to slow down on the amount of B12 you are taking
Given the increasing real-world use of combined therapy and the limited HF-specific evidence base, this review summarizes current data regarding the comparative and combined effects of GLP-1 receptor agonists and SGLT2 inhibitors in HF, with emphasis on efficacy, safety, mechanistic rationale, and evidence gaps
Some practitioners are very skilled in helping patients deal with these hinderances
If you use insulin or sulfonylureas, hypoglycemia risk may increase and may require medication adjustment
GLP-1 has a plasma half-life of only 1.5-3 min with a high clearance indicating degradation in blood (52, 72)
Gastrointestinal upset is infrequent but has been noted (e.g